Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

108.89 -0.22 (-0.20%)
Official Closing Price Updated: 7:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,595,629
Open 110.09
Bid (Size) 108.75 (1)
Ask (Size) 110.26 (1)
Prev. Close 109.11
Today's Range 108.83 - 110.89
52wk Range 89.67 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.87%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Buy Rated Stocks To Consider As Earnings Approach
With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation. 
Via Talk Markets
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc. 
Via Benzinga

Performance

YTD
-0.87%
-0.87%
1 Month
-3.16%
-3.16%
3 Month
-4.28%
-4.28%
6 Month
+18.13%
+18.13%
1 Year
+4.18%
+4.18%

More News

Read More
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
Via Investor's Business Daily
Abbott Laboratories Dividend Stock Analysis
Via Talk Markets
Abbott Laboratories Unusual Options Activity
Via Benzinga
Analyst Ratings For Abbott Laboratories
Via Benzinga
How Is The Market Feeling About Abbott Laboratories?
Via Benzinga
Performance Comparison: Abbott Laboratories And Competitors In Health Care Equipment & Supplies Industry
Via Benzinga
What the Options Market Tells Us About Abbott Laboratories
Via Benzinga
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Via The Motley Fool
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
Via InvestorPlace
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
Via Benzinga
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
Via The Motley Fool
3 Top Dividend Stocks to Buy in April 2024
Via The Motley Fool
Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks
Via Talk Markets
FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries
Via Benzinga
Exposures Product Safety
DexCom Stock Gains from GLP-1 Diabetic Users
Via MarketBeat
Russell 2000 Index Best And Worst Performing Stocks Of 2024
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List
Via InvestorPlace
Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval
Via InvestorPlace
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’
Via InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now.
Via The Motley Fool
3 Stocks to Buy Right Now for the Coming Recession
Via InvestorPlace
Topics Economy
Exposures Economy
3 Resilient Stocks to Protect Your Wealth During a Recession
Via InvestorPlace
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)
Via AB Newswire
Topics Death
Exposures Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.